Vitamin D-AMP Axis Enhances Host Defense Against Invasive Fungal Infections

Invasive fungal infections, caused by pathogens like Candida, Aspergillus, and Cryptococcus, pose significant global health challenges, especially with rising drug resistance. Traditional antifungals often face limitations, necessitating novel host-defense strategies. Antimicrobial peptides (AMPs), endogenous short protein chains, offer a promising alternative due to their broad-spectrum activity and lower propensity for resistance. Vitamin D has emerged as a critical immunomodulator, with its bioactive form, 1,25-dihydroxyvitamin D3, binding to the vitamin D receptor (VDR) to upregulate AMPs, presenting a potential pathway to bolster innate immunity against these difficult-to-treat infections.

This review article synthesized recent findings on the role of Vitamin D in inducing antimicrobial peptides (AMPs) within the context of invasive fungal infections. The authors distinguished Vitamin D's function as a host immune modulator from its potential as a direct antifungal compound. They critically evaluated the limitations of direct antifungal use, citing challenges such as supraphysiologic dosing requirements, pharmacologic impracticality, and risks of hypercalcemia and hyperphosphatemia. The review also discussed model limitations and species differences, particularly regarding primate-specific CAMP vitamin D response element regulation.

The review highlighted that optimal Vitamin D levels are essential for activating antimicrobial pathways and regulating AMPs that target multiple fungal pathogens. It underscored Vitamin D's primary role as a host immune modulator, enhancing the body's intrinsic defenses rather than acting as a direct antifungal agent. Direct antifungal application of Vitamin D3 is limited by the need for supraphysiologic doses, which carry significant risks like hypercalcemia and hyperphosphatemia, especially in patients with granulomatous diseases. The article emphasized that Vitamin D signaling through the VDR induces expression of AMPs such as cathelicidin (LL-37) and β-defensins, which are crucial for direct pathogen neutralization. Species-specific differences, particularly in CAMP gene regulation, mean that direct translation of rodent Vitamin D-to-LL-37 findings to human fungal disease is constrained. The review focused on Candida, Aspergillus, and Cryptococcus as key pathogens in invasive fungal disease.

Optimal Vitamin D levels are critical for activating antimicrobial pathways and regulating AMPs, serving as a first line of defense against invading fungal pathogens.